作者的详细信息

Косталанова, Юлия Владимировна

期 栏目 标题 文件
卷 20, 编号 2 (2018) Articles Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer PDF
(Rus)
卷 21, 编号 2 (2019) Articles The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience PDF
(Rus)
卷 21, 编号 1 (2019) Articles Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia PDF
(Rus)
卷 24, 编号 4 (2022) CLINICAL ONCOLOGY Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study PDF
(Rus)
卷 26, 编号 1 (2024) Articles Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia PDF
(Rus)
卷 26, 编号 1 (2024) Articles Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study PDF
(Rus)
卷 26, 编号 2 (2024) Articles Immunohistochemical factors of prognosis of immunotherapy for metastatic melanoma: А prospective and retrospective study PDF
(Rus)

##common.cookie##